Quantifying the Intragenic Distribution of Human Disease Mutations

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Annals of Human Genetics

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1529-8817.2003.00072.xPMID 14641244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cystic Fibrosis

  2009influential reference
• Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants

  2003cited by this paper
• Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease

  2003cited by this paper
• The functional importance of disease-associated mutation

  2002cited by this paper
• Evolutionary analyses of the human genome

  2001cited by this paper
• Human disease genes

  2001cited by this paper
• Understanding human disease mutations through the use of interspecific genetic variation.

  2001cited by this paper
• Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency.

  2000cited by this paper
• Molecular genetic advances in tuberous sclerosis

  2000cited by this paper
• PAHdb: A locus‐specific knowledgebase

  2000cited by this paper
• Human mutations in glucose 6‐phosphate dehydrogenase reflect evolutionary history

  2000cited by this paper
• The structural basis of phenylketonuria.

  1999cited by this paper
• Evolution of the ?F508 CFTR mutation

  1999cited by this paper
• Evolution of the delta F508 CFTR mutation.

  1999cited by this paper
• Salmonella typhi uses CFTR to enter intestinal epithelial cells

  1998cited by this paper
• The Human PAX6 Mutation Database

  1998cited by this paper
• PAX6 mutations reviewed

  1998cited by this paper
• CFTR: Domains, Structure, and Function

  1997cited by this paper
• Modeling of Nucleotide Binding Domains of ABC Transporter Proteins Based on a F1-ATPase/recA Topology: Structural Model of the Nucleotide Binding Domains of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)

  1997cited by this paper
• The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.

  1997cited by this paper
• PAX-6 in development and evolution.

  1997cited by this paper
• A Guide to Chi-Squared Testing

  1996cited by this paper
• Hematologically important mutations: glucose-6-phosphate dehydrogenase.

  1996cited by this paper
• Protection against bronchial asthma by CFTR ΔF508 mutation: A heterozygote advantage in cystic fibrosis

  1995cited by this paper
• Accounting for cystic fibrosis

  1988cited by this paper
• Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions.

  1986cited by this paper
• Phylogenies and the Comparative Method

  1985cited by this paper

• Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges

  2024cites this paper
• Statistical Dissection of the Genetic Determinants of Phenotypic Heterogeneity in Genes with Multiple Associated Rare Diseases

  2023cites this paper
• Human Genomic Variants and Inherited Disease

  2019cites this paper
• Evaluación de rendimiento y eficiencia energética de sistemas heterogéneos para bioinformática

  2018cites this paper
• Glucose-6-Phosphate Dehydrogenase Deficiency.

  2016cites this paper
• KinView: a visual comparative sequence analysis tool for integrated kinome research.

  2016cites this paper
• Mapping the genotype-phenotype relationship in complex disease.

  2016cites this paper
• An energy‐aware performance analysis of SWIMM: Smith–Waterman implementation on Intel's Multicore and Manycore architectures

  2015cites this paper
• Prediction of pathological mutations in proteins: the challenge of integrating sequence conservation and structure stability principles

  2014cites this paper
• Human gene mutation in inherited disease: Molecular mechanisms and clinical consequences

  2013cites this paper
• Molecular diagnostics of rare inherited SYNDROMES with a view on diagnostic test development

  2012cites this paper
• Relating the Disease Mutation Spectrum to the Evolution of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)

  2012cites this paper
• Comparative Analysis and Functional Mapping of SACS Mutations Reveal Novel Insights into Sacsin Repeated Architecture

  2012cites this paper
• Human Gene Mutation: Mechanisms and Consequences

  2010cites this paper
• Pharmacogenetics in medico-legal context.

  2010cites this paper
• Algorithms for genome comparison applied to bacterial genomes. (Algorithmes de comparaison de génomes appliqués aux génomes bactériens)

  2010cites this paper
• Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics

  2010cites this paper
• Evolutionary analyses of KCNQ1 and HERG voltage-gated potassium channel sequences reveal location-specific susceptibility and augmented chemical severities of arrhythmogenic mutations

  2008influential citation
• Evolutionary anatomies of positions and types of disease-associated and neutral amino acid mutations in the human genome

  2006cites this paper
• Fold Designability, Distribution, and Disease

  2006cites this paper
• The vertebrate connexin family

  2006cites this paper
• Evolutionary distance estimation and fidelity of pair wise sequence alignment

  2005cites this paper
• Distribution of the strength of selection against amino acid replacements in human proteins.

  2005cites this paper
• Sequence‐based prediction of pathological mutations

  2004cites this paper
• Candidate nsSNPs that can affect the functions and interactions of cell cycle proteins

  2004cites this paper
• Psychiatric genetics: What to expect

  2004cites this paper
• Absence of SIX6 mutations in microphthalmia, anophthalmia, and coloboma.

  2004cites this paper
• Glucose-6-Phosphate Dehydrogenase Deficiency.

  1995cites this paper